Update: All Four Core Pillars of My Work Have Now Been Independently Validated, Yet Remain Uncited

Over the past year, multiple research groups have published findings that independently replicate the central pillars of my published hypothesis, now formalized as a theory, on autism and the comorbidities along the BH4 pathway. These replications span Japan, Brazil, Stanford, and Princeton. Each group reproduced a different pillar of my model while presenting it as a novel conclusion. None cite my work, despite the conceptual overlap and the clear public timeline.

Here is where we stand.

1. Genetic Allostasis (Japan)
My original pillar: genetically induced allostatic activation creates an internal stress response that drives the system-level pattern seen in autism.
Replication: a Japanese group used pathway analysis and reported that ASD-associated genetic variants converge on the same stress-response pathways I identified. Their description of convergent internal stress signaling matches the genetic allostasis pillar.

2. The BH4 Shunt Pivot (Brazil)
My original pillar: BH4 shifts into a shunt during allostasis, redirecting neurotransmitter synthesis, upregulating transamination pathways, and contributing to autism-specific traits. When BH4 is diverted into the shunt during allostasis, it upregulates transamination pathways that reroute amino acid metabolism toward stress-adaptive intermediates. This reinforces the neurotransmitter imbalance and metabolic signatures observed in autism and its comorbidities.
Replication: a Brazilian team emphasized BH4 dysregulation as a unifying mechanism for autism-related symptoms, describing the same pivot I published years ago. Their text reflects the BH4 shunt mechanism without citation.

3. CSTL Neurotransmitter Dysregulation (Stanford)
My original pillar: BH4 shunt alters dopamine and serotonin output, shifting aromatic amino acid towards transamination reactions. This dysregulates the excitatory and inhibitory balance in the cortico striatal thalamic loop, which is the circuit responsible for movement, habit formation, and reward processing, producing classic autism traits.
Replication: Stanford isolated and targeted the excitatory and inhibitory balance within a specific section of this loop to treat autism symptoms. Their intervention worked because they “unknowingly” acted on a single branch of the broader mechanism.

4. Epigenetic BioToggle Activation Through NOS Uncoupling (Brazil)
My original pillar: chronic NOS uncoupling activates epigenetic redox-sensitive protein shunts that create the comorbidity clusters seen in autism.
Replication: Brazil reported the same NOS uncoupling cascade leading to widespread cellular dysregulation, which aligns directly with the epigenetic BioToggle pillar.

5. Phenotype Biochemical Trait Clusters (Princeton)
My original pillar: phenotype clusters in autism arise from shared biological mechanisms. When allostatic pathways shift, they produce predictable combinations of traits and comorbidities based on conserved gene coded protein activity. The clustering pattern emerges from the biology itself and remains stable because gene coded proteins are 99.9 percent conserved across humans.
Replication: Princeton approached the problem in reverse. They looked at autism data first, grouped together traits and health issues that appeared in the same individuals, and then tried to infer the biology afterward. This approach cannot produce a real mechanistic model because actual people carry too many uncontrolled variables. Their results depended on who happened to be in their dataset, not on how the biology works.

They used a bioinformatics tool called ShinyGo to calculate fold enrichment of gene coded protein pathways aligned with each trait cluster they created from SPARK data, which is already collected. No new biological data were generated. Their ShinyGo search was completed on June 3, 2024, and their submission to Nature followed on July 25, 2024.

Taken in isolation, each replication might seem unremarkable. Researchers often rediscover fragments of larger systems without realizing it.
But what matters is the pattern.

Four separate groups, in four different countries, reproduced the core pillars of the same framework. Each captured a different part of the same system. Each aligned with the same biochemical logic. And all of them match the biologically sound mechanism I mapped years earlier in my published hypothesis, now solidified as a theory.

Individually, these findings are small.
Collectively, they are validation.

This level of coordinated convergence across genetics, neurotransmitters, redox biology, and phenotype clustering does not happen by accident. It validates the coherence and accuracy of the mechanism at the center of my theory.

My goal remains constructive. The neurodivergent community deserves accuracy, transparency, and collaboration that builds on existing work instead of erasing it. This framework was created for families, educators, and clinicians who need clarity and transparency, not appropriation.

If you wish to support this effort for accountability and scientific integrity, you can:

• sign and share the Change.org petitions
• send the stock advocacy email to institutions or researchers
• share this update on social media to increase awareness

Thank you to everyone following this work. Your support helps drive forward Neurodivergent Biochemistry.